PATENT CLAIM ANALYSIS

Application Number: 15975723
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "465000"]

Abstract:
Disclosed herein is, among other things, a soft gel vaginal pharmaceutical composition and dosage form containing solubilized estradiol for the treatment of vulvovaginal atrophy (VVA) and female sexual dysfunction (FSD).

Claim (Index 14):
The method of  claim 12 , wherein a dosage form comprising the estradiol is manually inserted about two inches into the vagina.

Metadata:
- Claim Count in Document: 21.0
- Percentile: 93.0
- Lexical Diversity: 1.12121
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15893546', '15893542', '15372385', '15893550', '14521230']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8362981338685102
- 35 USC 102 Novelty (BERT): 0.6046338419531486
- Combined Prediction Score: 0.8131317046769739
- Mean Citation Score: 623.065186
- Max Citation Score: 717.0466
- Similarity Product: 463.1879329827785

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test